Abstract |
In recent years, progress has been made in understanding how peptides presented by MHC Class I molecules were generated, in particular which proteases are involved in this process and how intracellular pathways influence antigen presentation in professional antigen-presenting cells and various types of tumor cells. This review will give an overview of MHC Class I abnormalities in malignancies and their underlying molecular mechanisms. Dependent on the tumor types structural alterations in particular of the MHC Class I heavy chain, beta(2)-m and the TAP1 subunit have been found at a low frequency, whereas dysregulation of MHC Class I antigen processing components appears to be the major mechanism of MHC Class I down-regulation in tumors of distinct origin. This could occur at the epigenetic, transcriptional and/or post-transcriptional level. The lack or suppression of MHC Class I surface expression due to antigen-processing deficiencies are accompanied by reduced recognition and lysis by antigen-specific cytotoxic T-lymphocytes, which is further often associated with disease progression.
|
Authors | Barbara Seliger |
Journal | Journal of immunotoxicology
(J Immunotoxicol)
Vol. 5
Issue 4
Pg. 361-7
(Oct 2008)
ISSN: 1547-6901 [Electronic] England |
PMID | 19404870
(Publication Type: Journal Article, Review)
|
Chemical References |
- ATP Binding Cassette Transporter, Subfamily B, Member 2
- ATP-Binding Cassette Transporters
- Histocompatibility Antigens Class I
- TAP1 protein, human
- beta 2-Microglobulin
- Peptide Hydrolases
- Proteasome Endopeptidase Complex
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B, Member 2
- ATP-Binding Cassette Transporters
(physiology)
- Antigen Presentation
(immunology)
- Down-Regulation
(immunology)
- Histocompatibility Antigens Class I
(immunology)
- Humans
- Neoplasms
(immunology, physiopathology)
- Peptide Hydrolases
(physiology)
- Proteasome Endopeptidase Complex
(physiology)
- beta 2-Microglobulin
(physiology)
|